National Science Foundation Awards Integrated Nano-Technologies an SBIR Grant to Further Develop Its BioDetect Nano-Scale System for Detecting Biological Agents

Mar 28, 2005, 00:00 ET from Integrated Nano-Technologies, LLC

    ROCHESTER, N.Y., March 28 /PRNewswire/ -- The National Science Foundation
 awarded a Small Business Innovation Research (SBIR) grant to Integrated Nano-
 Technologies (INT) for further research and development of its novel DNA
 detection technology.  The BioDetect(TM) technology platform and portable
 system, which integrates DNA and microelectronics, accurately detects the
 presence of biological agents, such as SARS, anthrax and smallpox, in as
 little as 20 minutes.  The two-year grant is for $500,000.
     "It is gratifying to receive this grant as it validates the value of INT's
 technology by a government agency, and accelerates our development program,"
 said Mike Connolly, Ph.D., J.D., CEO and founder of INT.  "The BioDetect
 System offers a solution to one of the greatest challenges in biosecurity --
 the rapid and accurate detection of biological agents in the field, not in a
     About INT's Technology
     Integrated Nano-Technologies' core technology is a unique integration of
 molecular biology, chemistry and microelectronics that facilitates the
 development of technically advanced detection systems and other devices.
 Biological agent identification is based on the ability of DNA probes on a
 microchip to attract and bind to specific sequences in the DNA of a target
 organism.  DNA is extracted from a sample and passed over a sensor, where it
 attaches to the organism-specific probes.  The attached strands are metalized
 through a chemical process, producing a strong electrical signal for computer
     The BioDetect platform consists of an electronic analyzer and single-use,
 disposable test cards.  Unlike other detection systems, BioDetect(TM)
 technology does not depend on polymerase chain reaction (PCR), and
 consequently does not share PCR's problems with speed, stability and
     About the National Science Foundation
     The National Science Foundation, an independent agency of the Federal
 Government, invites (by solicitation) eligible business concerns to
 participate in its programs.  NSF supports high quality projects on important
 scientific, engineering, or science/engineering education problems and
 opportunities that could lead to significant commercial and public benefit if
 the research is successful.
     About Integrated Nano-Technologies, LLC
     Rochester, NY-based Integrated Nano-Technologies, LLC is a leading
 innovator in highly accurate, sensitive, rapid, portable, electronic,
 biological agent identification technology.  Built around the BioDetect(TM)
 platform, INT's devices are highly portable and use disposable test cards to
 test field samples for numerous biological agents, including anthrax, in as
 little as 20 minutes.  Future developments of the platform will enable the
 medical community to identify specific illness-causing pathogens in patients
 without sending samples to laboratories, facilitating faster and more accurate
 treatment.  For more information about Integrated Nano-Technologies, call 585-
 334-0170 or visit INT's Web site at
     This press release contains forward-looking statements that are based upon
 our current expectations and speak only as of the date hereof. Our actual
 results may differ materially and adversely from those expressed in any
 forward-looking statements as a result of various factors and uncertainties,
 including our ability to successfully develop products, rapid technological
 change in our markets, changes in demand for our future products, legislative,
 regulatory and competitive developments and general economic conditions. We
 undertake no obligation to revise or update publicly any forward-looking
 statements for any reason.

SOURCE Integrated Nano-Technologies, LLC